CAM
EDIT icon

Costello Asset Management’s Editas Medicine EDIT Stock Holding History

Costello Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24K Hold
1,000
– – ﹤0.01% 629
2026
Q1 		$2.47K Buy
+1,000
New +$2.12K ﹤0.01% 624

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Costello Asset Management's EDIT Position: Q2 2026 in Review

Costello Asset Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 1,000 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #629.

Costello Asset Management first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Costello Asset Management held 1,000 shares of Editas Medicine worth $3.24K as of Q2 2026.
  • Costello Asset Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Costello Asset Management's portfolio in Q2 2026, its #629 holding.
  • Costello Asset Management first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.